Pediatric Skin Failure

Katie E Cohen1, Matthew C Scanlon1, Amin Bemanian1

  • 1Katie E. Cohen is a medical student, Matthew C. Scanlon is a professor of pediatrics, and Amin Bemanian is a medical student at the Medical College of Wisconsin, Milwaukee, Wisconsin. Christine A. Schindler is a clinical assistant professor, College of Nursing, Marquette University, Milwaukee, Wisconsin.

Insights

Critically ill children with severe organ dysfunction may experience acute skin failure, not preventable pressure ulcers. This condition, linked to multiple organ dysfunction syndrome (MODS), has a high mortality rate in pediatric intensive care units.

Area of Science:

  • Pediatric critical care medicine
  • Dermatology
  • Pathophysiology of critical illness

Background:

  • Skin failure is recognized in adults but often misclassified as pressure ulcers in children.
  • Current pediatric literature indiscriminately groups severe skin injuries as pressure ulcers.

Purpose of the Study:

  • To identify and characterize the phenomenon of acute skin failure in critically ill pediatric patients.
  • To differentiate acute skin failure from traditional pressure ulcers in this population.

Main Methods:

  • Retrospective chart review of 19 pediatric patients with serious skin injuries.
  • Analysis of organ dysfunction scores, medications, pressure ulcer prevention, and laboratory values preceding skin lesion development.

Main Results:

  • All patients had preventive measures in place; injuries were full-thickness upon identification.
  • 18/19 patients had multiple organ dysfunction syndrome (MODS) with at least 2 dysfunctional systems.
  • Mortality rate was 42% in this cohort, significantly higher than the general pediatric intensive care unit population (1.8%).

Conclusions:

  • A subset of severe skin injuries in critically ill children may represent acute skin failure secondary to MODS.
  • This challenges the traditional view of pressure ulcers as entirely preventable in this vulnerable group.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
336
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K